Tarsus Pharmaceuticals, Inc. (TARS)
NGS · Common · CUSIP 87650L103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TARS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
87650L103
Market Cap
Small Cap
IPO
10/16/2020 · $16.00/share
Business: Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives.

Company Contact

CEO
Bobak Azamian
CFO
Leo M. Greenstein
Headquarters
15440 Laguna Canyon Road, Suite 160, Irvine, CA 92618
Phone
949-409-9820
Investor Relations
David Nakasone · 949-620-3223 · DNakasone@tarsusrx.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »